The biological seed treatment market is projected to reach USD 1,251.4 Million by 2022, at a CAGR of 11.10% from 2017. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development such as compatible combinations of biological and chemical components is expected to drive the growth of the market over the next five years.
Companies such as BASF (Germany), Bayer (Germany), Syngenta (Switzerland), Monsanto (US), and DuPont (US) have been focusing on technological innovations in seed inoculation and patent registrations for new product launches to strengthen their market base in the concerned market. Apart from these companies, other biological seed treatment companies include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert (Netherlands), Italpollina (Italy), and Incotec (Netherlands), which have been strengthening their market position through product launches and distribution & technology agreements.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288
Expansions were the most used strategy by the key players in the seed treatment market. R&D centers/innovation labs were inaugurated by companies such as BASF (Germany), Syngenta (Switzerland), Koppert (Netherlands), and Incotec (Netherlands). Due to the overall growing demand for biostimulants and microbial-based technologies, companies such as BASF (Germany), Incotec (Netherlands), Valent BioSciences (US), and Italpollina (Italy) have invested in the upgradation & expansion of their existing facilities or establishment of new manufacturing facilities.
Bayer is one of the active players in the biological seed treatment market. A considerable amount of Bayer revenue goes into research & development activities to offer innovative products and practices to the farming community across the world. Bayer has successfully pushed products into the market through its farmer engagement programs. Bayer has made significant investments in the acquisition of seed treatment technology providers and established research collaborations for the development of microbial seed treatment products through its SeedGrowth business unit. In July 2017, the company launched two inoculant technologies for seed treatment in Brazil. In September 2016, the company entered into a research collaboration with Forschungszentrum Juelich (Germany). This collaboration was expected to study the process by which microbial seed treatments affect the root growth and colonization of root system by microbes.
Make an Inquiry:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162422288
Syngenta has been a leading player in the agricultural industry by offering diverse innovative solutions to the market place. Through its product investment & partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions, and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In May 2016, Syngenta launched the brand EPIVIO, a range of biostimulants for reducing abiotic stress in plants through seed treatment.
